Trial Profile
Prospective, Randomized, Controlled, Observer-Blind Trial to Measure the Efficacy, Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine and the Safety and Immunogenicity of Quadrivalent Meningococcal Polysaccharide Diphtheria Conjugate Vaccine in Pregnant Malian Women and Their Infants up to 6 Months of Age
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 01 May 2020 Results of a pooled analysis of NCT01430689, NCT01034254 and NCT02465190 published in the Pediatric Infectious Disease Journal
- 13 Feb 2018 Results of a pooled analysis of NCT01430689, NCT01034254 and NCT02465190 (n=10,002) assessing the effect of antenatal influenza vaccination on all-cause severe infant pneumonia, published in the Pediatric Infectious Disease Journal
- 13 Apr 2017 Status changed from active, no longer recruiting to completed.